{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:25:28Z","timestamp":1789129528592,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ctro.2026.101259","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:51:48Z","timestamp":1786377108000},"page":"101259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The role of radiation therapy in leptomeningeal disease from breast cancer \u2013 a multicenter analysis"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-1755","authenticated-orcid":false,"given":"Felix","family":"Ehret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Aitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Niemierko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammy M.","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1294-6082","authenticated-orcid":false,"given":"Shane S.","family":"Neibart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayal A.","family":"Aizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy U.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Sammons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ctro.2026.101259_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.02.025","article-title":"Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis","volume":"168","author":"Boire","year":"2017","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.ctro.2026.101259_bb0010","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/neuonc\/noae103","article-title":"Leptomeningeal metastases from solid tumors: a SNO and ASCO consensus review on clinical management and future directions","volume":"26","author":"Wilcox","year":"2024","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2026.101259_bb0015","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","article-title":"Epidemiology of brain metastases and leptomeningeal disease","volume":"23","author":"Lamba","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"22","key":"10.1016\/j.ctro.2026.101259_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228534","article-title":"Management of brain and leptomeningeal metastases from breast cancer","volume":"21","author":"Pellerino","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ctro.2026.101259_bb0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-013-1175-6","article-title":"Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis","volume":"114","author":"Yust-Katz","year":"2013","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.breast.2012.10.009","article-title":"Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis","volume":"22","author":"Torrej\u00f3n","year":"2013","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clbc.2016.07.002","article-title":"Characteristics and outcomes of patients with breast cancer with leptomeningeal metastasis","volume":"17","author":"Morikawa","year":"2017","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"10.1016\/j.ctro.2026.101259_bb0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1200\/JCO.19.00457","article-title":"Osimertinib in patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer and leptomeningeal metastases: the BLOOM study","volume":"38","author":"Yang","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41523-023-00519-0","article-title":"Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan","volume":"9","author":"Alder","year":"2023","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41523-023-00584-5","article-title":"Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and\/or leptomeningeal disease (ROSET-BM)","volume":"9","author":"Niikura","year":"2023","journal-title":"NPJ Breast Cancer"},{"issue":"5","key":"10.1016\/j.ctro.2026.101259_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101624","article-title":"Leptomeningeal metastasis from solid tumours: EANO-ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"8","author":"Le Rhun","year":"2023","journal-title":"ESMO Open"},{"issue":"5","key":"10.1016\/j.ctro.2026.101259_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noz024","article-title":"The RANO leptomeningeal metastasis group proposal to assess response to treatment\u202f: lack of feasibility and clinical utility and a revised proposal","volume":"21","author":"Le Rhun","year":"2019","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cncr.30911","article-title":"Leptomeningeal metastasis from systemic cancer: review and update on management","volume":"124","author":"Wang","year":"2018","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ctro.2026.101259_bb0070","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11912-023-01432-2","article-title":"Diagnostic and therapeutic updates in leptomeningeal disease","volume":"25","author":"Roy-O\u2019Reilly","year":"2023","journal-title":"Curr Oncol Rep"},{"issue":"11","key":"10.1016\/j.ctro.2026.101259_bb0075","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/jamaoncol.2025.3007","article-title":"Proton craniospinal irradiation for patients with leptomeningeal metastasis: a randomized clinical trial","volume":"11","author":"Yang","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101259_bb0080","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3389\/fonc.2019.01224","article-title":"Radiotherapy in leptomeningeal disease: a systematic review of randomized and non-randomized trials","volume":"9","author":"Buszek","year":"2019","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101259_bb0085","article-title":"Radiation therapy in the management of leptomeningeal disease from solid tumors","volume":"9","author":"Barbour","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101259_bb0090","article-title":"Early outcomes from proton craniospinal irradiation for leptomeningeal metastasis from solid Tumors","volume":"10","author":"Lam","year":"2025","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13014-025-02618-7","article-title":"Early experience with proton craniospinal irradiation in adult patients with leptomeningeal disease","volume":"20","author":"Ehret","year":"2025","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101259_bb0100","article-title":"Volumetric modulated arc therapy craniospinal irradiation utilizing a vertebral body sparing approach: an alternative approach to improve access and minimize toxicity","volume":"9","author":"Perlow","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1005803918194","article-title":"Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy","volume":"35","author":"Chamberlain","year":"1997","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02967482","article-title":"Meningeal carcinomatosis in patients with breast cancer: report of 8 patients","volume":"8","author":"Yu","year":"2001","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-007-9340-4","article-title":"Breast cancer leptomeningeal metastasis--the role of multimodality treatment","volume":"84","author":"Rudnicka","year":"2007","journal-title":"J Neuro-Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101259_bb0120","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","article-title":"Survival of breast cancer patients with meningeal carcinomatosis","volume":"21","author":"Gauthier","year":"2010","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101259_bb0125","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11060-010-0524-y","article-title":"Meningeal carcinomatosis in breast cancer: prognostic factors and outcome","volume":"104","author":"de Azevedo","year":"2011","journal-title":"J Neuro-Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101259_bb0130","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10549-011-1682-0","article-title":"Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations","volume":"129","author":"Lee","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ctro.2026.101259_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1524-4741.2012.01228.x","article-title":"Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancer","volume":"18","author":"Lara-Medina","year":"2012","journal-title":"Breast J"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11060-013-1092-8","article-title":"A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer","volume":"113","author":"Le Rhun","year":"2013","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clbc.2014.07.004","article-title":"Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy","volume":"15","author":"Niwi\u0144ska","year":"2015","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2026.101259_bb0150","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10549-014-3054-z","article-title":"Leptomeningeal disease and breast cancer: the importance of tumor subtype","volume":"146","author":"Abouharb","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctro.2026.101259_bb0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.breast.2017.07.015","article-title":"Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: a single-centre experience","volume":"36","author":"Kingston","year":"2017","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11060-018-2790-z","article-title":"Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM)","volume":"138","author":"Niwi\u0144ska","year":"2018","journal-title":"J Neuro-Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101259_bb0165","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1634\/theoncologist.2018-0200","article-title":"Clinicopathological and treatment-associated prognostic factors in patients with breast Cancer leptomeningeal metastases in relation to tumor biology","volume":"23","author":"Griguolo","year":"2018","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.ctro.2026.101259_bb0170","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10549-019-05170-7","article-title":"Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy","volume":"175","author":"Figura","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13058-024-01789-7","article-title":"Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective review","volume":"26","author":"Wallace","year":"2024","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ctro.2026.101259_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104433","article-title":"Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC","volume":"81","author":"Laakmann","year":"2025","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.ctro.2026.101259_bb0185","doi-asserted-by":"crossref","first-page":"24170","DOI":"10.1038\/s41598-025-07191-3","article-title":"Survival outcomes among patients with breast cancer and leptomeningeal disease","volume":"15","author":"Id Said","year":"2025","journal-title":"Sci Rep"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:22:19Z","timestamp":1789125739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"alternative-id":["S2405630826001540"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101259","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of radiation therapy in leptomeningeal disease from breast cancer \u2013 a multicenter analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101259"}}